Home
News
News archive
Diamond Information


home > news Two-dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds

Two-dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds




A two-dose version of Johnson & Johnson's coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday -- making a two-dose regimen of J&J's Janssen vaccine comparable to a two-dose regimen of Moderna's or Pfizer's.



Click Here to read the entire article...



Find this article in Google